These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 11384635)
1. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle-stimulating hormone: a comparison of recombinant human chorionic gonadotropin (rhCG) and urinary hCG. International Recombinant Human Chorionic Gonadotropin Study Group Fertil Steril; 2001 Jun; 75(6):1111-8. PubMed ID: 11384635 [TBL] [Abstract][Full Text] [Related]
2. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment--recombinant HCG versus urinary HCG. The European Recombinant Human Chorionic Gonadotrophin Study Group. Hum Reprod; 2000 Jul; 15(7):1446-51. PubMed ID: 10875887 [TBL] [Abstract][Full Text] [Related]
3. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Youssef MA; Abou-Setta AM; Lam WS Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604 [TBL] [Abstract][Full Text] [Related]
4. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Driscoll GL; Tyler JP; Hangan JT; Fisher PR; Birdsall MA; Knight DC Hum Reprod; 2000 Jun; 15(6):1305-10. PubMed ID: 10831560 [TBL] [Abstract][Full Text] [Related]
5. [A randomized, single-blind, parallel-controlled and multicentre study: compare the efficacy and safety of domestic and imported human recombinant FSH in WHO group Ⅱ anovulatory infertility]. Zhou YZ; Shen H; Zuo WL; Xu YH; Deng XH; Chen YL; Gao Y; Wang XX; Xu W; Lai QH; Shi H; Liu W; He Q; He FF Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):258-63. PubMed ID: 27116983 [TBL] [Abstract][Full Text] [Related]
6. Relationship of baseline ovarian volume to ovarian response in World Health Organization II anovulatory patients who underwent ovulation induction with gonadotropins. Lass A; Vassiliev A; Decosterd G; Warne D; Loumaye E Fertil Steril; 2002 Aug; 78(2):265-9. PubMed ID: 12137861 [TBL] [Abstract][Full Text] [Related]
7. Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. European Recombinant LH Study Group J Clin Endocrinol Metab; 2001 Jun; 86(6):2607-18. PubMed ID: 11397861 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Chang P; Kenley S; Burns T; Denton G; Currie K; DeVane G; O'Dea L Fertil Steril; 2001 Jul; 76(1):67-74. PubMed ID: 11438321 [TBL] [Abstract][Full Text] [Related]
9. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles. Youssef MA; Al-Inany HG; Aboulghar M; Mansour R; Abou-Setta AM Cochrane Database Syst Rev; 2011 Apr; (4):CD003719. PubMed ID: 21491386 [TBL] [Abstract][Full Text] [Related]
10. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Burgués S; Hum Reprod; 2001 Dec; 16(12):2525-32. PubMed ID: 11726569 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols. Carone D; Caropreso C; Vitti A; Chiappetta R J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369 [TBL] [Abstract][Full Text] [Related]
12. Phase IV, open-label, randomized study of low-dose recombinant human follicle-stimulating hormone protocols for ovulation induction. Serour GI; Aboulghar M; Al Bahar A; Hugues JN; Esmat K Reprod Biol Endocrinol; 2014 Jun; 12():52. PubMed ID: 24942155 [TBL] [Abstract][Full Text] [Related]
13. Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility. Howles CM; Alam V; Tredway D; Homburg R; Warne DW Reprod Biomed Online; 2010 Feb; 20(2):182-90. PubMed ID: 20113956 [TBL] [Abstract][Full Text] [Related]
14. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878 [TBL] [Abstract][Full Text] [Related]
15. Recombinant versus urinary human chorionic gonadotrophin for ovulation induction in assisted conception. Al-Inany HG; Aboulghar M; Mansour R; Proctor M Cochrane Database Syst Rev; 2005 Apr; (2):CD003719. PubMed ID: 15846677 [TBL] [Abstract][Full Text] [Related]
16. Recombinant human luteinizing hormone to trigger ovulation: randomized, controlled, dose-finding pilot study in ovulation induction. Pierson RA; Olatunbosun OA; Chizen DR; Saunders H; Loumaye E; De Moustier B J Reprod Med; 2014; 59(7-8):355-66. PubMed ID: 25098025 [TBL] [Abstract][Full Text] [Related]
17. Comparing the efficacy of urinary and recombinant hCG on oocyte/follicle ratio to trigger ovulation in women undergoing intracytoplasmic sperm injection cycles: a randomized controlled trial. Madani T; Mohammadi Yeganeh L; Ezabadi Z; Hasani F; Chehrazi M J Assist Reprod Genet; 2013 Feb; 30(2):239-45. PubMed ID: 23274511 [TBL] [Abstract][Full Text] [Related]
18. Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients. Balasch J; Fábregues F; Peñarrubia J; Creus M; Vidal R; Casamitjana R; Manau D; Vanrell JA J Assist Reprod Genet; 1998 Oct; 15(9):552-9. PubMed ID: 9822984 [TBL] [Abstract][Full Text] [Related]
19. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Berkkanoglu M; Isikoglu M; Aydin D; Ozgur K Fertil Steril; 2007 Sep; 88(3):665-9. PubMed ID: 17292895 [TBL] [Abstract][Full Text] [Related]
20. Age-matched comparison of recombinant and urinary HCG for final follicular maturation. Uhler ML; Beltsos AN; Grotjan HE; Lederer KJ; Lifchez AS Reprod Biomed Online; 2006 Sep; 13(3):315-20. PubMed ID: 16984755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]